Market Cap 1.92B
Revenue (ttm) 105.97M
Net Income (ttm) -81.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 23.38
Profit Margin -76.56%
Debt to Equity Ratio 0.00
Volume 563,700
Avg Vol 694,410
Day's Range N/A - N/A
Shares Out 73.02M
Stochastic %K 84%
Beta 1.13
Analysts Strong Sell
Price Target $39.69

Company Profile

Zymeworks Inc., a biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases. The company's platforms include Azymetric multispecific antibody platform; Drug Conjugate platform that includes a suite of proprietary cytotoxins comprising topoisomerase and microtubulin inhibiting toxins, stable linkers, and conjugation technologies; EFECT platform, which consists of a set of modifications to the Fc region of antibodies; and ProTECT, a tumor-sp...

Industry: Biotechnology
Sector: Healthcare
Phone: 302 274 8744
Address:
108 Patriot Drive, Suite A, Middletown, United States
Night_Owl_Biotech
Night_Owl_Biotech Jul. 3 at 4:35 PM
The XBI is up 25% over the last 15 days & is now trading at record highs (excluding that 11 day period in Feb 2021 when it traded over $160/share). There are now 6 commercial-stage oncology focused bios hanging around the $2B MC range. Here's how this peer group has traded over the last 15 days. $URGN has been the biggest winner up 36%. We suspect an exit is imminent. $IOVA $NUVB $ANAB $ZYME
1 · Reply
maplelakeduckslayer
maplelakeduckslayer Jul. 3 at 4:00 AM
$ZYME sheep farmer celebrating his call this week
0 · Reply
TopTierNewswire
TopTierNewswire Jun. 30 at 9:52 PM
$FCEL , $BB , $ZYME - top runners on the Top Tier Newswire AI model. Huge gains today!
0 · Reply
Boris_Badenov
Boris_Badenov Jun. 30 at 7:34 PM
$ZYME An interesting part of the Theravance deal is the $2.5 billion in Irish tax attributes. So, let's see, is there an Ireland based biotech company that could figure out a use for these? Oh, here's one, Jazz Pharma.
2 · Reply
NoBSPls
NoBSPls Jun. 30 at 6:30 PM
$ZYME Bought in Dec 2022. Average $6.70. The beauty of “Get it and Forget it”.
0 · Reply
mostbullish
mostbullish Jun. 30 at 6:15 PM
$ZYME sorry that’s 12%
0 · Reply
mostbullish
mostbullish Jun. 30 at 6:14 PM
$ZYME to buy here you need to understand what EcoR1 and zymeworks are building and why. Institutions are chasing the stock price. Up 11% on average volume.
0 · Reply
mostbullish
mostbullish Jun. 30 at 6:12 PM
$ZYME who wants to buy at cash flow positiv biotech with predictable royalties and huge potential upside on oncology pipeline incl. ZW191 and a validated ADC platform. Almost like a bond with a mega million coupon 🤣. ExoR1 is dressing up Zyme for a sale.
0 · Reply
Mikelonggggggggg
Mikelonggggggggg Jun. 30 at 6:00 PM
1 · Reply
Nickhzap
Nickhzap Jun. 30 at 5:43 PM
$ZYME bahahahhahahahahahhaahhahahhahahahahahahahhahahahahah 🤡🤡🤡🤡🤡🤡🤡🤡🤡🤡
0 · Reply
Latest News on ZYME
Zymeworks price target raised to $37 from $34 at Wells Fargo

2026-06-30T10:25:21.000Z - 4 days ago

Zymeworks price target raised to $37 from $34 at Wells Fargo


Zymeworks price target raised to $37 from $35 at Citi

2026-06-30T09:45:22.000Z - 4 days ago

Zymeworks price target raised to $37 from $35 at Citi

TBPH


Zymeworks Transcript: M&A announcement

Jun 29, 2026, 8:30 AM EDT - 5 days ago

Zymeworks Transcript: M&A announcement


Zymeworks Press release: M&A announcement

Jun 29, 2026, 8:30 AM EDT - 5 days ago

Zymeworks Press release: M&A announcement


Zymeworks Slides: M&A announcement

Jun 29, 2026, 8:30 AM EDT - 5 days ago

Zymeworks Slides: M&A announcement


Zymeworks to Acquire Theravance Biopharma, Inc.

Jun 29, 2026, 6:00 AM EDT - 5 days ago

Zymeworks to Acquire Theravance Biopharma, Inc.


Zymeworks assumed with a Buy at Truist

2026-06-09T12:13:20.000Z - 25 days ago

Zymeworks assumed with a Buy at Truist


Zymeworks authorizes share repurchase program of up to $125M

2026-05-14T22:14:23.000Z - 7 weeks ago

Zymeworks authorizes share repurchase program of up to $125M


Zymeworks reports Q1 EPS (59c), consensus (10c)

2026-05-07T21:19:18.000Z - 2 months ago

Zymeworks reports Q1 EPS (59c), consensus (10c)


Zymeworks Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Zymeworks Earnings Call Transcript: Q1 2026


Zymeworks Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Zymeworks Earnings release: Q1 2026


Zymeworks Slides: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Zymeworks Slides: Q1 2026


Zymeworks Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Zymeworks Quarterly report: Q1 2026


Zymeworks appoints new Head of R&D and Chief Business Officer

2026-04-09T10:11:05.000Z - 3 months ago

Zymeworks appoints new Head of R&D and Chief Business Officer


Zymeworks appoints Kristin Stafford as CFO

2026-04-01T10:06:59.000Z - 3 months ago

Zymeworks appoints Kristin Stafford as CFO

NVCR


Zymeworks Appoints Kristin Stafford as Chief Financial Officer

Apr 1, 2026, 6:00 AM EDT - 3 months ago

Zymeworks Appoints Kristin Stafford as Chief Financial Officer


Zymeworks receives FDA Fast Track Designation for ZW191

2026-03-30T10:06:54.000Z - 3 months ago

Zymeworks receives FDA Fast Track Designation for ZW191


Zymeworks announces Fast Track designation for ZW191 by FDA

2026-03-30T10:05:07.000Z - 3 months ago

Zymeworks announces Fast Track designation for ZW191 by FDA


Zymeworks Transcript: The Citizens Life Sciences Conference 2026

Mar 11, 2026, 10:10 AM EDT - 4 months ago

Zymeworks Transcript: The Citizens Life Sciences Conference 2026


Zymeworks Transcript: Leerink Global Healthcare Conference 2026

Mar 9, 2026, 3:00 PM EDT - 4 months ago

Zymeworks Transcript: Leerink Global Healthcare Conference 2026


Zymeworks Earnings Call Transcript: Q4 2025

Mar 2, 2026, 8:30 AM EST - 4 months ago

Zymeworks Earnings Call Transcript: Q4 2025


Zymeworks Earnings release: Q4 2025

Mar 2, 2026, 8:30 AM EST - 4 months ago

Zymeworks Earnings release: Q4 2025


Zymeworks Slides: Q4 2025

Mar 2, 2026, 8:30 AM EST - 4 months ago

Zymeworks Slides: Q4 2025


Zymeworks Annual report: Q4 2025

Mar 2, 2026, 8:30 AM EST - 4 months ago

Zymeworks Annual report: Q4 2025


Zymeworks Slides: Corporate presentation

Feb 27, 2026, 7:00 AM EST - 4 months ago

Zymeworks Slides: Corporate presentation


Zymeworks Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:00 PM EST - 6 months ago

Zymeworks Slides: 44th Annual J.P. Morgan Healthcare Conference


Zymeworks Slides: Corporate presentation

Jan 12, 2026, 7:00 AM EST - 6 months ago

Zymeworks Slides: Corporate presentation


Zymeworks Outlines Strategic Priorities and Outlook for 2026

Jan 11, 2026, 6:00 PM EST - 6 months ago

Zymeworks Outlines Strategic Priorities and Outlook for 2026


Zymeworks Announces Participation in Upcoming Conferences

Dec 2, 2025, 4:05 PM EST - 7 months ago

Zymeworks Announces Participation in Upcoming Conferences


Zymeworks Transcript: Investor Update

Nov 18, 2025, 8:30 AM EST - 8 months ago

Zymeworks Transcript: Investor Update


Zymeworks Press release: Investor Update

Nov 18, 2025, 8:30 AM EST - 8 months ago

Zymeworks Press release: Investor Update


Zymeworks Slides: Investor Update

Nov 18, 2025, 8:30 AM EST - 8 months ago

Zymeworks Slides: Investor Update


Zymeworks Proxy statement: Proxy filing

Nov 10, 2025, 7:00 AM EST - 8 months ago

Zymeworks Proxy statement: Proxy filing


Zymeworks Proxy statement: Proxy filing

Nov 10, 2025, 7:00 AM EST - 8 months ago

Zymeworks Proxy statement: Proxy filing


Zymeworks Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Zymeworks Earnings Call Transcript: Q3 2025


Zymeworks Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Zymeworks Earnings release: Q3 2025


Zymeworks Slides: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Zymeworks Slides: Q3 2025


Zymeworks Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Zymeworks Quarterly report: Q3 2025


Zymeworks Transcript: Study Result

Oct 23, 2025, 3:30 PM EDT - 9 months ago

Zymeworks Transcript: Study Result


Zymeworks Press release: Study Result

Oct 23, 2025, 3:30 PM EDT - 9 months ago

Zymeworks Press release: Study Result


Zymeworks Slides: Corporate Presentation

Oct 22, 2025, 6:00 PM EDT - 9 months ago

Zymeworks Slides: Corporate Presentation


Zymeworks halts development of cancer drug after trial setback

Sep 2, 2025, 6:18 AM EDT - 10 months ago

Zymeworks halts development of cancer drug after trial setback


Zymeworks Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Zymeworks Earnings Call Transcript: Q2 2025


Zymeworks Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Zymeworks Quarterly report: Q2 2025


Zymeworks Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Zymeworks Earnings release: Q2 2025


Zymeworks Slides: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Zymeworks Slides: Q2 2025


Zymeworks Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Zymeworks Earnings Call Transcript: Q1 2025


Zymeworks Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Zymeworks Quarterly report: Q1 2025


Zymeworks Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Zymeworks Earnings release: Q1 2025


Zymeworks Slides: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Zymeworks Slides: Q1 2025


Zymeworks Earnings Call Transcript: Q4 2024

Mar 5, 2025, 4:30 PM EST - 1 year ago

Zymeworks Earnings Call Transcript: Q4 2024


Zymeworks Annual report: Q4 2024

Mar 5, 2025, 4:30 PM EST - 1 year ago

Zymeworks Annual report: Q4 2024


Zymeworks Earnings release: Q4 2024

Mar 5, 2025, 4:30 PM EST - 1 year ago

Zymeworks Earnings release: Q4 2024


Zymeworks Slides: Q4 2024

Mar 5, 2025, 4:30 PM EST - 1 year ago

Zymeworks Slides: Q4 2024


Night_Owl_Biotech
Night_Owl_Biotech Jul. 3 at 4:35 PM
The XBI is up 25% over the last 15 days & is now trading at record highs (excluding that 11 day period in Feb 2021 when it traded over $160/share). There are now 6 commercial-stage oncology focused bios hanging around the $2B MC range. Here's how this peer group has traded over the last 15 days. $URGN has been the biggest winner up 36%. We suspect an exit is imminent. $IOVA $NUVB $ANAB $ZYME
1 · Reply
maplelakeduckslayer
maplelakeduckslayer Jul. 3 at 4:00 AM
$ZYME sheep farmer celebrating his call this week
0 · Reply
TopTierNewswire
TopTierNewswire Jun. 30 at 9:52 PM
$FCEL , $BB , $ZYME - top runners on the Top Tier Newswire AI model. Huge gains today!
0 · Reply
Boris_Badenov
Boris_Badenov Jun. 30 at 7:34 PM
$ZYME An interesting part of the Theravance deal is the $2.5 billion in Irish tax attributes. So, let's see, is there an Ireland based biotech company that could figure out a use for these? Oh, here's one, Jazz Pharma.
2 · Reply
NoBSPls
NoBSPls Jun. 30 at 6:30 PM
$ZYME Bought in Dec 2022. Average $6.70. The beauty of “Get it and Forget it”.
0 · Reply
mostbullish
mostbullish Jun. 30 at 6:15 PM
$ZYME sorry that’s 12%
0 · Reply
mostbullish
mostbullish Jun. 30 at 6:14 PM
$ZYME to buy here you need to understand what EcoR1 and zymeworks are building and why. Institutions are chasing the stock price. Up 11% on average volume.
0 · Reply
mostbullish
mostbullish Jun. 30 at 6:12 PM
$ZYME who wants to buy at cash flow positiv biotech with predictable royalties and huge potential upside on oncology pipeline incl. ZW191 and a validated ADC platform. Almost like a bond with a mega million coupon 🤣. ExoR1 is dressing up Zyme for a sale.
0 · Reply
Mikelonggggggggg
Mikelonggggggggg Jun. 30 at 6:00 PM
1 · Reply
Nickhzap
Nickhzap Jun. 30 at 5:43 PM
$ZYME bahahahhahahahahahhaahhahahhahahahahahahahhahahahahah 🤡🤡🤡🤡🤡🤡🤡🤡🤡🤡
0 · Reply
JFDI
JFDI Jun. 30 at 2:27 PM
yo b, what $ZYME is it ?
0 · Reply
NyseDayTrader
NyseDayTrader Jun. 30 at 2:04 PM
$ZYME 🤣
1 · Reply
MikeyMcDermott
MikeyMcDermott Jun. 29 at 9:31 PM
$SPRO DO NOT SELL TO $ZYME $GSK please. Thank you
0 · Reply
buzzkiller
buzzkiller Jun. 29 at 8:31 PM
$ZYME thank you for the shares Sellers - I hope the cash exchange serves you well.
0 · Reply
Nickhzap
Nickhzap Jun. 29 at 4:08 PM
$TBPH $ZYME 😂😂😂🤡🤡🤡🤡
0 · Reply
BuyingSheep
BuyingSheep Jun. 29 at 1:45 PM
$ZYME sure, 😂 🤡
1 · Reply
BuyingSheep
BuyingSheep Jun. 29 at 1:44 PM
$ZYME you nailed it, MM 😂
1 · Reply
mikesterz7
mikesterz7 Jun. 29 at 1:42 PM
$TBPH $ZYME Theravance Biopharma shareholders will receive a contingent value right (CVR) under which they will get 80% of the net proceeds from any future license, divestiture, or monetization of ampreloxetine over the next ten years.
0 · Reply
JFais
JFais Jun. 29 at 1:04 PM
Didn't have $ZYME as an acquirer in my bingo card $TBPH (zero premium, $XBI doesn't like such deals) The next great (& unsexy) royalty aggregator (diversifying revenues & racking up tax benefits)
1 · Reply
JFais
JFais Jun. 29 at 12:58 PM
Didn't have $ZYME as an acquirer in my bingo card $TBPH
0 · Reply
OpenOutcrier
OpenOutcrier Jun. 29 at 12:52 PM
$TBPH (-3.1% pre) Theravance Biopharma to Be Acquired by $ZYME Zymeworks for $17 Per Share Plus CVR https://ooc.bz/l/106467
0 · Reply
StocktwitsNews
StocktwitsNews Jun. 29 at 12:44 PM
Zymeworks To Buy Theravance Biopharma In $929M Deal – A Look At What This Deal Means For TBPH Shareholders $TBPH $ZYME https://stocktwits.com/news/equity/markets/tbph-zyme-takeover-deal-929-million-ampreloxetine/cZ19JeQR7hM
0 · Reply